Quinupristin dalfopristin indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Quinupristin dalfopristin }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SYNERCID (QUINUPRISTIN AND DA...")
 
No edit summary
 
Line 3: Line 3:
{{CMG}}; {{AE}} {{chetan}}
{{CMG}}; {{AE}} {{chetan}}


==Indications And Usage==


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SYNERCID (QUINUPRISTIN AND DALFOPRISTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28f698df-b584-4455-2e94-6efc41313960 | publisher =  | date =  | accessdate = }}</ref>
Synercid is indicated in adults for the treatment of the following infections when caused by susceptible strains of the designated microorganisms.
 
Complicated skin and skin structure infections caused by [[Staphylococcus aureus ]](methicillin susceptible) or [[Streptococcus pyogenes]]. (See Clinical Studies.) <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SYNERCID (QUINUPRISTIN AND DALFOPRISTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28f698df-b584-4455-2e94-6efc41313960 | publisher =  | date =  | accessdate = }}</ref>





Latest revision as of 05:39, 9 January 2014

Quinupristin dalfopristin
SYNERCID ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Indications And Usage

Synercid is indicated in adults for the treatment of the following infections when caused by susceptible strains of the designated microorganisms.

Complicated skin and skin structure infections caused by Staphylococcus aureus (methicillin susceptible) or Streptococcus pyogenes. (See Clinical Studies.) [1]


References

  1. "SYNERCID (QUINUPRISTIN AND DALFOPRISTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]".

Adapted from the FDA Package Insert.